肥胖相关疾病的相对风险

数据集获取（Figshare）

• 源站标题：<p>Relative risks of obesity-associated diseases.</p>
• DOI：10.1371/journal.pone.0344040.t001
• 发布日期：2026-03-04
• 文件数：1 个
• 文件总体积：13.82 KB
• 源站页面：https://plos.figshare.com/articles/dataset/_p_Relative_risks_of_obesity-associated_diseases_p_/31504516

命令行下载

curl -L -o "Table 1.xls" "https://ndownloader.figshare.com/files/62395903"

文件清单

• Table 1.xls（13.82 KB）

文件总体积 13.82 KB（源站 API 实测）。

数据说明

Background
Obesity is a complex public health issue that has risen to epidemic proportions globally. The aim of this study was to estimate the economic costs associated with obesity from governmental and societal perspectives in the State of Kuwait in 2024.
Methods
A disease-specific prevalence-based cost-of-illness framework was applied. Key parameters include prevalence of obesity and its related comorbidities, relative risks, healthcare resources, income rate and growth, and lost workdays for patients and relatives, all were derived from literature. The outcomes measured were total healthcare costs, societal costs, and cost per patient, all reported in 2024 Kuwaiti Dinar (KWD), United States dollar ($), and Purchasing Power Parity (PPP).
Results
In 2024, there were approximately 2 million morbidity cases and 961 mortality cases directly attributed to obesity in Kuwait. The economic burden of obesity was estimated at KWD 4.3 billion ($ 14 billion; PPP$ 21.6 billion) from societal perspective and KWD 3.9 billion ($12.8 billion, PPP 19.7 billion) from governmental perspective, almost 1.3 times healthcare budget. The mean annual societal cost per patient was KWD 1,737 ($5,676; PPP 8,729)—17.6% of 2024 Kuwaiti gross domestic product per capita. Furthermore, the mean direct medical cost per patient was KWD 1,586 ($5,184 or PPP 7,972); comprised 3 times the healthcare expenditure per capita.
Conclusion
Obesity and its comorbidities impose a far greater health and economic burden on Kuwait’s healthcare system and national productivity than previously recognized. This study calls for a paradigm shift toward early prevention, culturally tailored strategies, and comprehensive disease management. Expanding access to emerging innovative treatments and leveraging technology-driven tools are essential to support sustained weight management and reduce long-term impacts.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0344040.t001（source: https://plos.figshare.com/articles/dataset/_p_Relative_risks_of_obesity-associated_diseases_p_/31504516）。